CAS: 2225819-06-5
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | BAY-2402234 REF: TM-T14501CAS: 2225819-06-5 | 98.90% | 173,00 €~1.644,00 € | Vie 09 May 25 |
 | BAY-2402234 REF: 54-BUP04771CAS: 2225819-06-5 | ≥98% | 1.226,00 €~2.226,00 € | Lun 12 May 25 |
 | BAY 2402234 REF: 3D-APD81906CAS: 2225819-06-5 | Min. 95% | A consultar | Vie 20 Jun 25 |
BAY-2402234
CAS:2225819-06-5
BAY-2402234: a selective DHODH inhibitor targeting myeloid cancers with low-nanomolar potency.
Fórmula:
C21H18ClF5N4O4
Pureza:
98.90%
Forma y color:
Solid
Peso molecular:
520.84
Ref: TM-T14501
| 1mg | 173,00 € | ||
| 2mg | 246,00 € | ||
| 5mg | 368,00 € | ||
| 10mg | 567,00 € | ||
| 25mg | 905,00 € | ||
| 50mg | 1.225,00 € | ||
| 100mg | 1.644,00 € | ||
| 1mL*10mM (DMSO) | 424,00 € |
Entrega estimada en Estados Unidos, el Viernes 9 de Mayo de 2025
Ref: 54-BUP04771
| 25mg | 1.226,00 € | ||
| 50mg | 1.659,00 € | ||
| 100mg | 2.226,00 € |
Entrega estimada en Estados Unidos, el Lunes 12 de Mayo de 2025
BAY 2402234
CAS:2225819-06-5
Please enquire for more information about BAY 2402234 including the price, delivery time and more …
Fórmula:
C21H18ClF5N4O4
Pureza:
Min. 95%
Peso molecular:
520.84 g/mol
Ref: 3D-APD81906
| 10mg | 1.064,00 € | ||
| 25mg | 1.734,00 € | ||
| 50mg | 2.702,00 € |
Entrega estimada en Estados Unidos, el Viernes 20 de Junio de 2025
